Implementation of a Pediatric-to-adult Asthma Transition Program

NCT ID: NCT01521247

Last Updated: 2016-09-09

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2010-04-30
• Study Completion Date: 2015-07-31

Brief Summary

Despite the clear and often stated need, a formal transition program does not exist for asthma patients as they move from pediatric to adult care in Western Canada. This population is not having their health care needs met. The investigators proposed study would evaluate a well structured transition program designed to facilitate continuity of care for this at risk patient population.

Primary hypothesis: A pediatric-to-adult asthma transition program will improve the asthma-specific quality of life of young asthma patients in the Calgary area over a 1 year period.

Secondary hypothesis: A pediatric-to-adult asthma transition program will improve asthma control, decrease asthma exacerbations, and reduce health care utilization in young asthma patients in the Calgary area over a 1 year period.

Conditions

Asthma; Education

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Blinding Strategy: NONE

Study Groups

Control group

Usual care.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Asthma Transition Program

Asthma Transition Program

Group Type: OTHER

Asthma Transition Program

Intervention Type: OTHER

Asthma Education.

Interventions

Asthma Transition Program

Asthma Education.

Intervention Type: OTHER

Other Intervention Names

Asthma Education and Referral.

Eligibility Criteria

Inclusion Criteria

• clinical diagnosis of asthma (as confirmed by a pediatric respirologist or pediatrician with asthma expertise, and including evidence of variable airflow obstruction, bronchial hyperresponsiveness, airway inflammation, and/or response to therapy)

Exclusion Criteria

• patients who are known to be non-adherent within the Calgary Regional Pediatric Asthma Clinic (defined as >50% missed appointments over a 2 year period)
• patients unable to complete pulmonary function testing
• patients with a history of significant respiratory comorbid conditions (including history of cystic fibrosis, alpha-1 antitrypsin deficiency, and lung transplant - rhinosinusitis patients will not be excluded)
• patients unable to provide consent.

• Minimum Eligible Age: 17 Years
• Maximum Eligible Age: 19 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Calgary

OTHER

Sponsor Role: lead

Responsible Party

Warren Davidson

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Mary Noseworthy, MD

Role: STUDY_DIRECTOR

Alberta Children's Hospital

Rodel Padua, RRT

Role: STUDY_DIRECTOR

Sheldon Spier, MD

Role: STUDY_DIRECTOR

Alberta Children's Hospital

Ward Flemons, MD

Role: STUDY_DIRECTOR

University of Calgary

Warren Davidson, MD

Role: PRINCIPAL_INVESTIGATOR

University of Calgary

Locations

Calgary Regional Pediatric Asthma Clinic

Calgary, Alberta, Canada

Countries

Canada

Other Identifiers

AJMG-2010

Identifier Type: -

Identifier Source: org_study_id